CHINA HONGGUANG (08646): Shenzhen and Li Investment plan to invest 100 million yuan to subscribe for equity in Jieyang Hongguang.
China Hongguang (08646) announced that its indirect wholly-owned subsidiary, Jieyang Hongguang Coated Glass Co., Ltd. (Jieyang Hongguang), is currently negotiating with Shenzhen Li Investment Co., Ltd. (an affiliate of Li International Quantitative Securities Partnership Fund) (Investor) regarding a capital increase. The preliminary intention is for the Investor to invest RMB 100 million to subscribe for equity in Jieyang Hongguang, resulting in an approximate 20% shareholding post-transaction. Both parties have agreed that the deadline for signing the formal agreement for this capital increase will be subject to the effective compliance due diligence completed by both sides.
CHINA HONGGUANG (08646) announced that its indirectly wholly-owned subsidiary, Jieyang Hongguang Coating Glass Co., Ltd. (Jieyang Hongguang), is currently discussing capital increase matters with Shenzhen Yili Investment Co., Ltd. (a company affiliated with Yili International Quantitative Securities Partnership Fund) (the investor). The preliminary intention is for the investor to contribute RMB 100 million to subscribe for equity in Jieyang Hongguang, resulting in an approximate 20% equity stake upon completion. Both parties have agreed that the deadline for the formal capital increase agreement signing will be based on the effectiveness of the compliance due diligence conducted by both sides.
Related Articles
SIPAI HEALTH (00314) has issued a positive profit forecast, expecting a net profit of 41 million to 44 million yuan in the first half of the year, achieving a turnaround from loss to profit year-on-year.
IPO News | Yundong Intelligent Resubmits Application to Hong Kong Stock Exchange as a Domestic Supplier of In-Vehicle Intelligent Connectivity Solutions
Stock prices surge! The "light in, copper out" trend of AI data centers has ignited testing demand, leading to additional orders for Aehr (AEHR.US), a leader in silicon photonics.
SIPAI HEALTH (00314) has issued a positive profit forecast, expecting a net profit of 41 million to 44 million yuan in the first half of the year, achieving a turnaround from loss to profit year-on-year.
IPO News | Yundong Intelligent Resubmits Application to Hong Kong Stock Exchange as a Domestic Supplier of In-Vehicle Intelligent Connectivity Solutions
Stock prices surge! The "light in, copper out" trend of AI data centers has ignited testing demand, leading to additional orders for Aehr (AEHR.US), a leader in silicon photonics.
RECOMMEND
